It has been reported that CTCs with higher CXCR3 expression can be recruited to the tumor site by ligands, including CXCL9, CXCL10, and CXCL11, which are known as IFNγ-inducible chemokines (12, 13). This evidence concerns the gene CXCR3 and neoplasm.